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Background: T follicular helper (Tfh) cells are crucial for B cell differentiation and antigen-specific antibody production. Dysregulation of Tfh-mediated B cell help weakens
B cell responses in HIV infection. Moreover, Tfh cells in the lymph node and peripheral
blood comprise a significant portion of the latent HIV reservoir. There is limited data on
the effects of perinatal HIV infection on Tfh cells in children. We examined peripheral Tfh
(pTfh) cell frequencies and phenotype in HIV-infected children and their associations with
disease progression, immune activation, and B cell differentiation.
Methods: In a Kenyan cohort of 76 perinatally HIV-infected children, comprised of 43
treatment-naïve (ART−) and 33 on antiretroviral therapy (ART+), and 42 healthy controls
(HIV−), we identified memory pTfh cells, T cell activation markers, and B cell differentiation states using multi-parameter flow cytometry. Soluble CD163 and intestinal fatty
acid-binding protein plasma levels were quantified by ELISA.
Results: ART− children had reduced levels of pTfh cells compared with HIV− children
that increased with antiretroviral therapy. HIV+ children had higher programmed cell
death protein 1 (PD-1) expression on pTfh cells, regardless of treatment status. Low
memory pTfh cells with elevated PD-1 levels correlated with advancing HIV disease
status, indicated by increasing HIV viral loads and T cell and monocyte activation,
and decreasing %CD4 and CD4:CD8 ratios. Antiretroviral treatment, particularly when
started at younger ages, restored pTfh cell frequency and eliminated correlations with
disease progression, but failed to lower PD-1 levels on pTfh cells and their associations
with CD4 T cell percentages and activation. Altered B cell subsets, with decreased naïve
and resting memory B cells and increased activated and tissue-like memory B cells in
HIV+ children, correlated with low memory pTfh cell frequencies. Last, HIV+ children
had decreased proportions of CXCR5+ CD8 T cells that associated with low %CD4 and
CD4:CD8 ratios.
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Conclusion: Low memory pTfh cell frequencies with high PD-1 expression in HIV+ children correlate with worsening disease status and an activated and differentiated B cell
profile. This perturbed memory pTfh cell population may contribute to weak vaccine and
HIV-specific antibody responses in HIV+ children. Restoring Tfh cell capacity may be
important for novel pediatric HIV cure and vaccine strategies.
Keywords: T follicular helper cells, HIV, children, immune activation, B cells, T follicular cytotoxic cells

INTRODUCTION

beneficial and pathologic roles during HIV infection—they
are critical for HIV-specific humoral responses yet are also
selective targets of HIV infection and enable HIV persistence
in latent reservoirs.
Both lymphoid and circulating Tfh cells have impaired
function in HIV+ adults, which may contribute to weakened
responses to vaccines (16, 20, 22, 23). The potential consequences of muted antibody responses are magnified in children
with perinatal HIV infection during routine childhood vaccinations. However, few studies have examined pTfh cells in children
(18–20, 24). We evaluated pTfh cell frequencies and phenotype
in children with perinatal HIV infection and their associations
with HIV disease progression and B cell subsets. We found
decreased pTfh cell levels in untreated HIV+ children compared
with HIV negative children, which failed to normalize within
1 year of antiretroviral treatment. pTfh cells had elevated PD-1
expression in HIV+ children regardless of treatment status. Low
pTfh cell frequencies with high PD-1 expression correlated with
HIV disease progression and an activate/differentiated B cell distribution. Finally, CXCR5+ memory CD8 T cells were depleted
in HIV+ children.

T follicular helper (Tfh) cells are a recently described CD4 T cell
subset that links the adaptive and humoral immune systems.
These cells are identified by expression of chemokine receptor
CXCR5 that directs their migration to B cell follicles in response
to CXCL13. Once localized in B cell follicles, Tfh cells form
germinal centers (GCs) (1). Their differentiation and functions are regulated by B-cell lymphoma 6 (Bcl-6) (2). Tfh cells
stimulate B cell differentiation to plasma and memory B cells (3)
and are critical for antigen-specific antibody production, class
switching, and B cell memory differentiation (4). During natural
infections or after vaccinations, Tfh cell interactions with B cells
mediate high affinity class-switched antibody production and
B cell memory development (3). Tfh cells exert effector functions by secretion of IL-21 in addition to small levels of Th1 and
Th2 cytokines IFNγ and IL-4 (4, 5). Dysfunctional Tfh cells can
result in autoantibodies and have been associated with autoimmune diseases such as rheumatoid arthritis and systemic lupus
erythematosus (6–10).
A small portion of CD4 T cells closely resembling tissueresident Tfh cells are found in the peripheral blood (10–12).
These peripheral Tfh (pTfh) cells also provide B cell help, but
require secondary signals that include CD40L and inducible
T-cell costimulator (ICOS) interactions and IL-21 secretion from
B cells (11). Phenotypically, pTfh cells differ from lymphoid Tfh
cells. Bcl-6 is downregulated in circulating CXCR5+ CD4 T cells,
and thus fails to identify pTfh cells (10, 11). Second, while programmed cell death protein 1 (PD-1) is constitutively expressed
on lymphoid Tfh cells, in the periphery, PD-1 is variably expressed,
with low levels on resting pTfh cells and high levels on activated
pTfh cells (12–14).
T follicular helper cells are critical for clearance of acute and
chronic viral infections and effective virus-specific antibody
production. In HIV vaccine trials, improved humoral responses
occurred in subjects with expanded HIV-specific IL-21+ pTfh
cells (14). Moreover, certain Tfh cell subsets correlate with the
development of broadly neutralizing HIV antibodies (13, 15).
Indeed, Tfh cells are being investigated for novel HIV vaccine
strategies (11, 13, 15). Studies of HIV-infected adults demonstrate that circulating Tfh cells are decreased while lymphoid
Tfh cells are paradoxically expanded, functionally impaired,
and preferentially infected with replication-competent HIV
(14, 16–20). Most importantly, Tfh cells in peripheral blood
and lymph nodes (LNs) comprise a major compartment of the
latent HIV reservoir (14, 21). Thus, Tfh cells may have both
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MATERIALS AND METHODS
Participants

Ethical approval for this study was obtained from New York
University (10-02586) and Kenyatta National Hospital/University
of Nairobi (P283/07/2011). Written informed consent and verbal
assent when appropriate were obtained from all participants and/
or parents. We enrolled a total of 76 perinatally infected HIV+ and
42 HIV negative-unexposed children (HIV−) aged 5–18 years old
from Bomu Hospital in Mombasa, Kenya between 2011 and 2012.
HIV+ children included 43 antiretroviral therapy naïve (ART−)
and 33 HIV+ children on antiretroviral treatment for at least
6 months with viral load less than or equal to 5,000 copies/mL
(ART+). Treatment timing and duration for ART+ subjects is
shown in Table S1 in Supplementary Material. Individuals with a
recent acute illness, active Mycobacterium tuberculosis or malaria
infection, or pregnancy within one year were ineligible for study
entry.
Plasma and peripheral blood mononuclear cells (PBMCs)
were isolated from peripheral blood by centrifugation and FicollHypaque (GE Healthcare) density gradient centrifugation then
cryopreserved in −80°C and liquid nitrogen, respectively. HIV
RNA PCR was performed on diluted plasma samples with Roche,
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RESULTS

Table 1 | Subject characteristics.

n
Age (years)d
Female
%CD4d
Absolute CD4
countd
HIV log
copies/mLd

HIV−

ART−

ART+

42
11 (9–13)
17 (41%)
38 (33–42)
923
(739–1,247)

43
11 (8–14)
23 (54%)
24 (13–28)
583
(352–812)
4.8 (4.2–5.2)

33
12 (8–13)
19 (58%)
32 (27–41)
962
(750–1,228)
2 (2–2)

p

Memory pTfh Cells Are Decreased in
Untreated HIV+ Children and Correlate
With Disease Progression

NSa
NSb
p < 0.0001a
p < 0.0001a

We identified pTfh cells by CXCR5 co-expressed with LN homing
receptor CCR7 within memory CD4 T cells as described (25).
Memory CD4 T cells (TM) were identified as the sum of central
(TCM, CD45RO+CCR7+), effector (TEM, CD45RO+ CCR7−), and
RA+ effector (TEMRA, CD45RO−CCR7−) subsets (Figure 1A).
CXCR5+CCR7+ CD4 TM (memory pTfh) levels were lower in
ART− children compared with HIV− and ART+ (p < 0.0001;
Figure 1B), even when adjusted for age as a potential confounder
(Table S2 in Supplementary Material).
In a subset of ART− children who began antiretroviral therapy
memory pTfh cell frequencies increased after ~12 months of
treatment (p = 0.003; Figure 1C). However, these levels remained
lower than HIV− children (p = 0.02; Figure 1C). In ART+ children, treatment initiation at an earlier age predicted preserved
CXCR5+CCR7+ CD4 TM (p = 0.01, R2 = 0.21; Figure 1D). To
determine the clinical relevance of decreased pTfh cell frequencies, we examined correlations between memory pTfh cells and
clinical markers of HIV disease progression. In HIV+ subjects,
memory pTfh cell levels correlated inversely with HIV viral load
(p < 0.0001, r = −0.59) and directly with %CD4 (p < 0.0001,
r = 0.57) and CD4:CD8 ratios (p < 0.0001, r = 0.54; Figure 1E).
In separate analyses of ART− and ART+ children, memory pTfh
frequencies correlated with %CD4 (p = 0.006, r = 0.43) and
CD4:CD8 ratios (p < 0.0001, r = 0.62) in ART− but not in ART+
children. These correlations were not present in HIV− subjects
(Figure S1A in Supplementary Material).

p < 0.0001c

Kruskal–Wallis test.
Chi squared test.
c
Mann–Whitney test.
d
Median values with upper and lower quartile range.
a

b

COBAS® AmpliPrep/COBAS® TaqMan®HIV-1 Test, version 2.0
(limit of detection 110 copies/mL).
HIV−, ART−, and ART+ were matched for age and sex
(Table 1). Median CD4% in HIV− children was 38 (IQR 33–42).
ART− had median CD4% of 24 (IQR 13–28) and HIV viral load
of 4.8 (IQR 4.2–5.2) log copies/mL. ART+ had median CD4%
and HIV viral load of 32 (IQR 27–41) and 2 (IQR 2–2) log copies/
mL, respectively (Table 1).

Flow Cytometric Studies

Cryopreserved PBMCs were evaluated by flow cytometry with
fluorescent-conjugated antibodies to CD3, CD4, CD8, CD45RO,
CCR7, CXCR5, PD-1, CD38, HLA-DR, CD19, CD21, CD27, and
β7. Cells were stained at 4°C for 30 min in PBS buffer containing
2% FCS and 0.1% sodium azide. Stained cells were analyzed using
LSRII flow cytometer (BD Bioscience) and Flow Jo software (Tree
Star). Singlet lymphocytes were gated based on forward and side
scatter properties.

Low Memory pTfh Cell Frequencies
Correlate With Immune Activation and Gut
Mucosal Disruption in HIV+ Children

Plasma sCD163 and Intestinal Fatty
Acid-Binding Protein (I-FABP)

We next determined whether memory pTfh cell levels correlated
with immune activation markers CD38 and HLA-DR, which
are strong predictors of HIV disease progression (26). Memory
pTfh cell frequencies inversely correlated with CD38+HLA-DR+
CD4 (p < 0.0001, r = −0.62) in HIV+ children and in separate
analysis of ART− (p = 0.003, r = −0.47) and ART+ subjects
(p = 0.04, r = −0.37; Figure 2A). Memory pTfh cell frequencies
also negatively correlated with CD38+HLA-DR+ CD8 T cells
(p = 0.006, r = −0.32) and monocyte activation, measured by
plasma sCD163 concentrations in HIV+ children (p < 0.0001,
r = −0.48), but not when divided into ART− and ART+ groups
(Figures 2A,B). There were no significant correlations between
pTfh cell frequencies and T cell or monocyte activation in HIV−
children (Figures S1B,C in Supplementary Material).
Chronic inflammation in HIV is driven largely by a compromise of the gut mucosa, where the majority of CD4 T cells
reside (27). In mouse models, Tfh cells have been shown to play
a unique role in maintaining healthy gut homeostasis (28). To
study a potential relationship between memory pTfh cells and the
gut mucosa in humans, we evaluated correlations with two key
gut-related proteins: β7 integrin and I-FABP. β7 is a subunit of

Plasma levels of sCD163 and I-FABP were quantified by ELISA
assay using Human sCD163 and I-FABP Duoset kits (R&D
Systems) per the manufacturer’s instructions. Plasma samples
were diluted 1:100 for sCD163 and 1:1,500 for I-FABP assays
based on plasma titration studies to achieve levels within the
range of the standard curve concentrations provided in the commercial ELISA kit according to the manufacturer’s recommendation. Each test was performed in duplicate with results reported
as the average of duplicate results.

Statistics

All statistical analyses were performed using GraphPad Prism
software. For comparison of multiple groups of subjects, the
Kruskal–Wallis test was performed, followed by the two-stage
linear step-up procedure of Benjamini, Krieger, and Yekutieli
to correct for multiple comparisons by controlling the false discovery rate. Multiple time points were evaluated with Wilcoxon
matched-pairs signed-rank test. Correlations were assessed with
the Spearman rank test. Threshold of significance for all tests was
less than 0.05.

Frontiers in Immunology | www.frontiersin.org

3

August 2018 | Volume 9 | Article 1901

McCarty et al.

pTfh Cells in HIV+ Children

Figure 1 | Memory peripheral Tfh (pTfh) cells are decreased in untreated HIV+ children and correlate with disease progression. (A) FACS plots showing
representative gating to identify memory pTfh cells in an HIV− and HIV+ subject. CD4 memory subsets were identified by CD45RO and CCR7 expression. Total
memory CD4 T cells (CD4 TM) were Boolean-gated as the sum of TCM, TEM, and TEMRA populations. Memory pTfh cells are identified as CXCR5+ CCR7+ cells within
CD4 TM. (B) The proportion of CXCR5+ CCR7+ cells in CD4 TM in HIV−, ART−, and ART+ children. (C) Memory pTfh cell frequencies in ART− subjects at before
(T0) and ~12 months after treatment (T1) is shown. The second plot shows memory pTfh cell levels in ART− subjects at T0 and T1 compared with HIV− subjects.
(D) Linear regression plot of memory pTfh cells vs. age at ART initiation in ART+ children. (E) Correlations between memory pTfh cell frequencies and HIV log
copies/mL, %CD4+ T cells, and CD4:CD8 ratios in HIV+ children (ART− in orange and ART+ in blue). Significant p values are shown for statistical analysis of HIV+
(black), ART− (orange), and ART+ (blue) groups (****p < 0.0001, ***p < 0.001, **p < 0.01, and *p < 0.05).

an indirect correlation in HIV+ children (p = 0.03, r = −0.26;
Figure 2D) but not separately in ART− and ART+ groups.

the gut-homing receptor and HIV co-receptor α4β7 (29). I-FABP
is expressed in epithelial cells of the small intestine and is released
into the circulation following intestinal mucosal damage (30).
Memory pTfh cell levels directly correlated with β7+CD45RO+
CD4 T cell frequencies, in both HIV− (p < 0.0001, r = 0.65) and
HIV+ children (p = 0.004, r = 0.34; Figure 2C). ART+ children
had a stronger correlation between pTfh cell frequency and β7
expression in memory CD4 T cells (p < 0.0001, r = 0.78) compared with ART− children (p = 0.046, r = 0.32; Figure 2C). There
was a direct correlation between memory pTfh cell frequencies
and I-FABP levels (p = 0.04, r = 0.35) in HIV− children, and

Frontiers in Immunology | www.frontiersin.org

Memory pTfh Cells in HIV+ Children
Express High PD-1 Levels That Correlate
With Disease Progression

We next evaluated PD-1 expression on memory pTfh cells (gating strategy shown in Figure S2A in Supplementary Material).
Both ART− and ART+ subjects had higher PD-1 expression on
memory pTfh cells compared with HIV− children (p < 0.0001
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Figure 2 | Low memory peripheral Tfh (pTfh) cell frequencies correlate with immune activation and gut mucosal disruption in HIV+ children. (A) Correlations
between memory pTfh cell frequencies and CD38+ HLA-DR+ CD4 and CD8 T cells in HIV+ children (ART− in orange and ART+ in blue). (B) Correlation between
memory pTfh cells and plasma soluble CD163 (sCD163) levels in HIV+ children. (C) Correlation between memory pTfh cell levels and (C) β7 integrin and (D)
intestinal fatty acid-binding protein (I-FABP) in HIV− (gray circles) and HIV+ children. Significant p values are shown for statistical analysis of HIV+ (black), ART−
(orange), and ART+ (blue) groups.

and p = 0.003, respectively; Figure 3A). PD-1 levels on memory
pTfh cells negatively correlated with pTfh cell frequency in HIV+
(p = 0.004, r = −0.34) and ART+ children (p = 0.03, r = −0.38)
but not in ART− children (Figure 3B). In ART+ children,
earlier age at ART initiation predicted lower PD-1 expression
on memory pTfh cells (p = 0.007, R2 = 0.22; Figure 3C). PD-1+
memory pTfh cell frequencies correlated directly with HIV viral
load (p = 0.004, r = 0.34), and inversely with %CD4 (p < 0.0001,
r = −0.46) and CD4:CD8 ratios in HIV+ children (p < 0.0001,
r = −0.51; Figure 3D) but not in HIV− children (Figure S2B
in Supplementary Material). PD-1+ expression on memory pTfh
cell correlated directly with CD38+HLA-DR+ CD4 (p = 0.0002,
r = 0.43) and CD8 T cells (p = 0.0009, r = 0.39; Figure 3E) but
did not correlate with plasma sCD163 levels (Figure 3F) in
HIV+ children. In ART− children, PD-1 expression on pTfh cells
significantly correlated with HIV viral load (p = 0.03, r = 0.35,
Figure 2D) and CD38+HLA-DR+ CD8 T cells (p = 0.002,
r = 0.49; Figure 3E). In ART+ children, PD-1 expression correlated inversely with %CD4 (p = 0.0001, r = −0.62) and CD4:CD8
ratios (p < 0.0001, r = −0.76; Figure 3D). There were no significant correlations between PD-1 expression on pTfh cells and
%CD4 or immune activation markers in HIV− children (Figures
S2C,D in Supplementary Material).

pTfh cell frequencies and PD-1 expression. Total B cell frequencies
were decreased in both ART− and ART+ compared with HIV−
children (p = 0.005 and p = 0.02, respectively; Figure 4A). IgD
expression on B cells was increased in ART− and ART+ children
compared with HIV− children (p = 0.002 and p = 0.0001, respectively; Figure 4B), indicating muted class switching. We further
sub-classified B cells into differentiation states of naïve mature
(BN, CD21+CD27−), resting memory (BRM, CD21+CD27+),
activated memory (BAM, CD21−CD27+), and exhausted/tissuelike memory (BTLM, CD21−CD27−; Figure 4C) subsets. ART+
had increased BN frequencies compared with HIV− and ART−
(p < 0.0001; Figure 4D). ART− and ART+ had decreased BRM
levels compared with HIV− (p < 0.0001; Figure 4E). BRM levels
were higher in ART+ compared with ART− children (p = 0.002;
Figure 4E). ART− had elevated BAM and BTLM cell frequencies
compared with HIV− (p = 0.003 and p < 0.0001) and ART+
(p < 0.0001; Figures 4F,G). ART+ had lower BAM frequencies
compared with HIV− (p = 0.003; Figure 4F).
We next examined associations between B cell differentiation
states and memory pTfh cell frequencies. In HIV+ subjects, memory
pTfh cell levels correlated directly with BN (p = 0.0001, r = 0.44;
Figure 4D) and BRM frequencies (p = 0.0003, r = 0.41; Figure 4E),
and inversely with BAM (p = 0.0002, r = −0.43; Figure 4F) and BTLM
frequencies (p < 0.0001, r = −0.52; Figure 4G). Last, in HIV+ subjects, PD-1 expression on memory pTfh cells correlated inversely with
BN (p = 0.03, r = −0.26; Figure 4D) and BRM (p = 0.002, r = −0.36;
Figure 4E), and directly with BAM (p = 0.046, r = 0.24; Figure 4F) and
BTLM levels (p = 0.0006, r = 0.40; Figure 4G). These correlations were
insignificant when separated into ART− and ART+ subjects except
PD-1 expression on pTfh cells in ART− children inversely correlated

Differentiated B Cell Populations Correlate
With Low Memory pTfh Cells Expressing
High PD-1 Levels

Because Tfh cells are intricately linked to B cell differentiation, we
evaluated B cell populations and their associations with memory
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Figure 3 | Memory peripheral Tfh (pTfh) cells in HIV+ children express high programmed cell death protein 1 (PD-1) levels that correlate with disease progression.
(A) Comparison between PD-1 expression memory pTfh cells of HIV−, ART−, and ART+ children. (B) Correlation between the frequency of total memory pTfh cells
and their PD-1 expression. (C) Linear regression plot of PD-1 expression on memory pTfh cells vs. age at ART initiation in ART+ subjects. (D) Correlations between
the frequency of PD-1+ memory pTfh cells and HIV log copies/mL, %CD4+ T cells, and CD4:CD8 ratios in HIV+ children (ART− in orange and ART+ in blue).
Correlations between PD-1 expression on memory pTfh and (E) CD38+ HLA-DR+ CD4 and CD8 T cells and (F) plasma sCD163 levels. Significant p values are
shown for statistical analysis of HIV+ (black), ART− (orange), and ART+ (blue) groups (****p < 0.0001, ***p < 0.001, **p < 0.01, and *p < 0.05).

with BN frequency (p = 0.02, r = −0.38; Figure 4D) and directly with
BTLM frequency (p = 0.003, r = 0.46; Figure 4G). Memory pTfh cells
and their PD-1 expression did not correlate with any B cell subpopulations in HIV− subjects (Figures S3A–D in Supplementary Material).

ART+ children compared with HIV− (p < 0.0001 and p = 0.0002,
respectively; Figure 5B) even in multivariate analysis adjusting
for age (Table S2 in Supplementary Material). In ART− subjects,
memory pTfc cell frequencies increased after ~12 months of
antiretroviral treatment (p = 0.004), but remained significantly
lower than HIV− children (p = 0.03; Figure 5C).
Next, we determined whether memory pTfc cell levels correlated with clinical markers of HIV disease progression and
immune activation. In HIV+ subjects, there was no significant
correlation between memory pTfc cell frequencies and HIV
viral load. Memory pTfc cells directly correlated with %CD4
(p = 0.0005, r = 0.39) and CD4:CD8 ratios (p = 0.0001, r = 0.43) in
HIV+ subjects even when divided into ART− and ART+ groups
(Figure 5D). In HIV− subjects, memory pTfc cell frequencies also
correlated with CD4 percentages and CD4:CD8 ratios (%CD4:
p = 0.02, r = 0.37; CD4:CD8: p = 0.02, r = 0.37; Figure S4A in

HIV+ Children Have Low CXCR5+ Memory
CD8 T Cells With Elevated PD-1
Expression

Recently, a CD8 T cell counterpart to Tfh cells, defined as follicular cytotoxic T (Tfc) cells, was found to home to B cell follicles
via a similar CXCR5-dependent mechanism (31). In the B cell
follicle, Tfc cells control viral infection by killing infected Tfh cells
and B cells (32, 33). We identified pTfc cells by CXCR5 expression
in memory CD8 T cells (Figure 5A). CXCR5+ CD8 TM (memory
pTfc) cell frequencies were significantly lower in both ART− and
Frontiers in Immunology | www.frontiersin.org
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Figure 4 | Continued
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Figure 4 | Differentiated B cell populations correlate with low memory peripheral Tfh (pTfh) cells expressing high programmed cell death protein 1 (PD-1) levels.
Comparisons of (A) total B cell and (B) IgD+ B cell levels in HIV−, ART−, and ART+ children. (C) FACS plot showing representative gating to identify B cell
differentiation subsets by CD21 and CD27. Plot shown is gated on CD19+ lymphocytes. Comparisons between (D) CD27−CD21+ naïve (BN), (E) CD27+ CD21+
resting memory (BRM), (F) CD27+ CD21− activated memory (BAM), and (G) CD27−CD21− tissue-like memory (BTLM) B cell subsets in HIV−, ART−, and ART+ and
their correlations with total and PD-1+ memory pTfh cell frequencies in ART− (orange) and ART+ (blue) children. Significant p values are shown for statistical
analysis of HIV+ (black), ART− (orange), and ART+ (blue) groups (****p < 0.0001, ***p < 0.001, **p < 0.01, and *p < 0.05).

Figure 5 | HIV+ children have low CXCR5+ memory CD8 T cells with elevated programmed cell death protein 1 (PD-1). (A) FACS plots showing representative
gating to identify memory pTfc cells as the total CXCR5+ population in memory CD8 T cells and PD-1 expression in an HIV− and HIV+ subject. Plots shown
were gated within total memory CD8 T cells. (B) Comparison of CXCR5+ cells within total CD8+ memory T cells in HIV−, ART−, and ART+ children. (C)
Prospective analysis of memory pTfc in ART− subjects before (T0) and ~12 months after antiretroviral treatment (T1). The second plot compares memory pTfc
cell frequencies between ART− subjects at T0 and T1 and HIV− subjects. (D) Correlations between memory pTfc cell percentages and HIV log copies/mL,
%CD4+ T cells, and CD4:CD8 ratios in HIV+ children (ART− in orange and ART+ in blue). (E) PD-1 expression on memory pTfc cells in HIV−, ART−, and ART+
subjects. (F) Correlation between PD-1+ memory pTfc cell frequencies and HIV log copies/mL, %CD4+ T cells, and CD4:CD8 ratios in HIV+ children.
Significant p values are shown for statistical analysis of HIV+ (black), ART− (orange), and ART+ (blue) groups (****p < 0.0001, ***p < 0.001, **p < 0.01, and
*p < 0.05).
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Supplementary Material). We also examined PD-1 expression on
memory pTfc cells and found that memory pTfc cells in HIV+
children expressed higher levels of PD-1 compared with HIV−
children (ART−: p < 0.0001, ART+: p = 0.001; Figure 5E). In
HIV+ children, PD-1 expression on memory pTfc cells inversely
correlated with CD4:CD8 ratios (p = 0.01, r = −0.29), but did
not correlate with %CD4 or viral load (Figure 5F). In ART+
subjects, HIV viremia correlated negatively with memory pTfc
cell frequency (p = 0.03, r = −0.39; Figure 1D) and directly with
PD-1 levels on memory pTfc cells (p = 0.04, r = 0.36; Figure 5F).
Memory pTfc cell frequencies and their PD-1 expression did not
correlate with CD38+HLA-DR+ CD4 or CD8 T cells or sCD163
plasma levels in HIV+ or HIV− children with the exception of a
direct correlation between PD-1+CXCR5+ CD8 TM and CD38+
HLA-DR+ CD8 T cells in HIV+ children (Figures S4B,C in
Supplementary Material).

which predicted higher pTfh levels. We speculate that with early
antiretroviral treatment, HIV+ children may be able to recover
memory pTfh cells, in accordance with the recent recommendation from the World Health Organization to start treatment at the
time of HIV diagnosis (35).
Programmed cell death protein 1 is a classic marker of
functional Tfh cells in the lymphoid tissue of healthy adults and
children, where PD-1/PD-L1 interactions in the GC are crucial
for plasma cell differentiation (36). However, there is some
uncertainty as to the role of PD-1 on circulating Tfh cells. PD-1
is a co-stimulatory molecule; it is absent on quiescent pTfh cells,
expressed on follicular regulatory T (Tfr) cells, and co-expressed
with ICOS on activated pTfh cells (37). Interestingly, we demonstrated PD-1 expression on memory pTfh cells was elevated
in all HIV+ children regardless of treatment status, and corresponded with worsening HIV disease progression. Moreover,
in ART+ children, PD-1 expression correlated with lower CD4
percentages and CD4:CD8 ratios and elevated CD4 T cell activation despite treatment. This indicates that while memory pTfh
frequencies recover with antiretrovirals, these cells may still be
qualitatively defective, with high PD-1 acting as a potentially
pathogenic marker, as has been suggested by previous studies
on HIV-specific CD4 (38) and CD8 (39) T cells. Alternatively
a portion of PD-1+ pTfh cells may be Tfr cells with suppressive
functions that account for low pTfh cell frequencies (40). Elevated
PD-1 expression on pTfh cells correlated with increasing CD38+
HLA-DR+ CD4 and CD8 T cells, suggesting PD-1+ pTfh cells
may be activated Tfh cells associated with inflammation in the
adaptive immune system. Interestingly, Pallikkuth et al. reported
that CD38+ HLA-DR+ expression on pTfh cells decreased after
48 weeks of treatment, but was still significantly higher than
healthy controls (21). This activated pTfh cell state likely contributes to their susceptibility as a target for HIV infection and may
be linked to high PD-1 expression.
T follicular helper cells also localize in the Peyer’s patches of
the small intestine. Because there are significant disruptions to
the intestinal mucosa during HIV infection, we examined the
relationship between Tfh cells and gut-homing receptor α4β7 and
I-FABP (41). It was previously shown that I-FABP is increased
in perinatally HIV-infected children (42). We found that low
memory pTfh cell frequencies in HIV+ subjects correlated with
higher plasma I-FABP and lower β7+ memory CD4 T cell levels.
One explanation may be that with worsening gut mucosal disruption, pTfh cells are trafficked to the gut. Localization to the gut may
also account for lower circulating pTfh cells during HIV infection.
Although we did not co-stain for CXCR5 and β7 together, pTfh
cells likely co-express β7 to mediate homing to the intestine.
It has been well documented that memory B cell populations
and the quality of B cell responses are substantially impaired in
HIV+ adults and children (43). More recent reports demonstrate
that inadequate B cell help by HIV-infected Tfh cells results in perturbed B cell differentiation and dysregulated antibody production
(16, 17). In addition, dysfunctional Tfh cells activate non-specific
B cells and lead to hypergammaglobulinemia characteristic of
HIV infection (34, 40). Prior groups have shown decreased BN
and BRM cell subsets, as well as expanded BAM and BTLM B cell
subsets in HIV+ children (18–20). In our study, we had similar

DISCUSSION
We demonstrated that untreated children with perinatal HIV
infection aged 5–18 years have significantly lower memory pTfh
cell frequencies compared with HIV-negative children. Low
memory pTfh levels increased with antiretroviral treatment but
failed to normalize. In ART+ children, treatment initiation at
younger ages predicted preserved pTfh levels. HIV+ children
had higher PD-1 expression on pTfh cells regardless of treatment
status. Furthermore, lower memory pTfh cells with increased
PD-1 expression correlated with worsening HIV disease and an
activated and differentiated B cell profile in HIV+ children. Last,
HIV+ children have decreased proportions of memory pTfc cells
with high PD-1 expression.
In our cohort, low memory pTfh cell frequencies correlated
with decreased %CD4 and CD4:CD8 ratios and increased HIV
viral load, which may reflect preferential infection of Tfh cells by
HIV (14). Muema et al. similarly reported that CXCR5+ CD4
T cells correlated with %CD4 in HIV+ children, yet Bamford
et al. failed to find any correlation between pTfh cell frequencies and clinical variables in children. This difference may relate
to treatment status, as in our cohort, where these correlations
were no longer significant when limited to only ART+ children.
While the mechanism of pTfh cell depletion in HIV is not well
understood, it is possible that like tissue-resident Tfh cells, pTfh
cells are preferentially HIV-infected and killed. It is also plausible
that pTfh cells in HIV+ subjects are ill-maintained as a result of
impaired crosstalk with B cells, as Tfh and B cells need constant
communication via co-stimulatory signals to maintain a homeostatic and healthy immune system (2, 16). Alternatively, Tfh cells
may be chronically activated and subsequently sequestered in the
LNs, depleting levels in the peripheral blood as shown in SIV
(34). While Pallikkuth et al. reported a reversible depletion of
CXCR5+ cells within TCM in adults with HIV (21), the recovery
of pTfh cells with antiretroviral therapy in children is previously
unreported. Treatment initiation raised pTfh cell frequencies in
ART− subjects, but failed to restore them to normal levels within
one year. However, our ART+ subjects had pTfh cell frequencies
similar to HIV− children. This may be due to longer duration of
antiretroviral treatment or younger age at treatment initiation,
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toward a differentiated and exhausted profile, and coincide with
decreased memory pTfh cells in HIV+ children. Finally, memory
pTfc cells are depleted in HIV+ children. This perturbed memory
pTfh cell population may contribute to weak vaccine and HIVspecific antibody responses in HIV+ children. Together, these
findings have important implications for ongoing pediatric HIV
cure and vaccine strategies.

findings—total B cells were diminished and IgD+ B cells were
elevated in HIV-infected children compared with healthy controls.
We also demonstrated that BN were increased in ART+, BRM were
low in HIV+, and BAM and BTLM were high in HIV+ compared with
healthy controls. While pTfh cell proportions were significantly
decreased in the blood, it is possible that with the accumulation
of Tfh cells in the LNs, overstimulation by GC Tfh cells in the
B cell follicles leads to a shift toward a more differentiated and
exhausted B cell state. Moreover, lower total B cells and elevated
IgD frequencies in HIV+ children suggest a general insult to the
B cell compartment and a defect in Tfh cell function to induce
class-switching in memory B cells. Decreased pTfh cells with
potentially impaired B cell function may preclude effective HIV
antibody responses. Indeed, prior studies report preserved pTfh
cells in subjects with broadly neutralizing HIV-specific antibody
responses (15, 44). Low pTfh cell frequency was closely linked to a
differentiated B cell state in HIV+ children but not when separated
into ART− and ART+ groups, suggesting antiretroviral treatment
may restore the balance of Tfh cells with B cell differentiation.
Finally, Tfc cells are a novel CD8 T cell subset expressing
CXCR5. Tfc cells have been studied in the blood and LN of SIV+
primate models (45, 46), the LNs of LCMV mouse models (33),
as well as the blood, tumors, and LN of adult humans (32, 33,
47–49). Multiple groups reported Tfc cells have similar B cell
follicle homing abilities to Tfh cells, and the potential to control
viral infection by eliminating infected T cells and B cells in the
follicle. He et al. reported that HIV-specific Tfc cells were present
in the blood of chronically infected adults, and pTfc cells inversely
correlated with HIV viral load prior to ART (33). More recently,
Jiao et al. reported HIV+ adults had increased CXCR5+ CD8
T cells with high PD-1 expression, which negatively correlated
with HIV disease progression (47). To the best of our knowledge,
pTfc cell populations in children were not previously studied.
HIV+ children had irreversibly depleted CXCR5+ CD8 TM cells.
Notably, antiretroviral treatment raised memory pTfc cell levels
but failed to normalize them. As such, pTfc cells directly correlated with %CD4 and CD4:CD8 ratios regardless of treatment
status. PD-1 expression was elevated on memory pTfc cells in
HIV+ children and negatively correlated with CD4:CD8 ratios
and positively associated with CD38+HLA-DR+ CD8 T cells.
Interestingly, whereas Jiao et al. concluded CXCR5+ CD8 T cells
with high PD-1 expression were highly functional and associated
negatively with disease progression, our data demonstrated an
association with CD4:CD8 ratios, but not with viremia or CD4
percentages. Our opposing findings may reflect differences in a
pediatric cohort or our separate gating strategy on CD8 memory
rather than total CD8 T cells.
In conclusion, we demonstrated a marked decrease in
peripheral memory Tfh frequencies in untreated children with
perinatal HIV infection. These memory pTfh cells increased
with antiretroviral therapy but failed to normalize within 1 year.
Treatment initiation at younger ages predicted greater recovery
of this population. HIV+ children have high PD-1 expression on
memory pTfh cells regardless of treatment status. Low memory
pTfh cell frequencies with high PD-1 levels correlate with worsening HIV disease status as well as innate and adaptive immune
activation. Furthermore, B cell subpopulations are skewed
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Figure S1 | Peripheral Tfh (pTfh) cell correlations with %CD4, CD4:CD8 ratios,
and immune activation in HIV negative children. Correlations between memory
pTfh cells and (A) %CD4 and CD4:CD8 ratios, (B) CD38+ HLA-DR+ CD4 and
CD8 T cells, and (C) plasma sCD163 levels in HIV negative children.
Figure S2 | PD-1+ memory peripheral Tfh (pTfh) cell gating and correlations in
HIV negative children. (A) FACS plots showing representative gating of PD-1+
memory pTfh cells in an HIV− and HIV+ subject. Plots shown were gated within
the CXCR5+ CCR7+ CD4+ TM population. Correlations are shown between
PD-1+ memory pTfh cells and (B) %CD4 and CD4:CD8 ratios, (C) CD38+
HLA-DR+ CD4 and CD8 T cells, and (D) plasma sCD163 levels in HIV negative
children.
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Figure S3 | Correlations between memory peripheral Tfh (pTfh) cells and
B cell subsets in HIV-negative children. Correlations between total and
PD-1+ memory pTfh cells and (A) CD27−CD21+ naïve (BN), (B) CD27+
CD21+ resting memory (BRM), (C) CD27+ CD21− activated memory (BAM),
and (D) CD27−CD21− tissue-like memory (BTLM) B cell subsets in HIV
negative children.

Figure S4 | CXCR5+ memory CD8 T cell subsets and correlations with T cell
activation. (A) Correlations between CXCR5+ CD8 TM cell frequencies and
%CD4 and CD4:CD8 ratios in HIV− children. Correlations between (B) total and
(C) PD-1+ CXCR5+ CD8 TM cell frequencies and CD38+ HLA-DR+ CD4 and
CD8 T cells and plasma sCD163 levels in HIV− and HIV+ children (ART− in
orange and ART+ in blue).
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